Aspen Wealth Strategies’s Merck MRK Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$302K Buy
2,514
+1
+0% +$115 0.16% 74
2025
Q4
$265K Buy
2,513
+27
+1% +$2.54K 0.14% 76
2025
Q3
$209K Buy
+2,486
New +$205K 0.12% 85
2025
Q2
Sell
-2,748
Closed -$247K 89
2025
Q1
$247K Buy
2,748
+282
+11% +$26.3K 0.16% 75
2024
Q4
$245K Sell
2,466
-15
-0.6% -$1.55K 0.16% 71
2024
Q3
$282K Sell
2,481
-205
-8% -$24.4K 0.18% 71
2024
Q2
$338K Buy
2,686
+125
+5% +$16.1K 0.24% 53
2024
Q1
$338K Sell
2,561
-90
-3% -$11.1K 0.23% 55
2023
Q4
$289K Buy
2,651
+33
+1% +$3.42K 0.21% 63
2023
Q3
$269K Buy
2,618
+31
+1% +$3.34K 0.21% 57
2023
Q2
$299K Sell
2,587
-215
-8% -$24.4K 0.23% 55
2023
Q1
$298K Sell
2,802
-148
-5% -$16K 0.23% 56
2022
Q4
$327K Buy
+2,950
New +$302K 0.26% 53

Other funds holding MRK

Aspen Wealth Strategies's MRK Position: Q1 2026 in Review

Aspen Wealth Strategies increased its Merck (MRK) stake by 0.04% in Q1 2026, buying an estimated $115 and bringing the position to 2,514 shares worth $302K. The position accounts for 0.16% of the portfolio, ranked #74.

Aspen Wealth Strategies first reported a position in MRK in Q4 2022 and has held it in 13 quarters since. The position peaked at $338K in Q2 2024. 3,778 funds tracked by Wall St. Rank hold MRK as of Q1 2026.

  • Aspen Wealth Strategies held 2,514 shares of Merck worth $302K as of Q1 2026.
  • Aspen Wealth Strategies bought 1 Merck share in Q1 2026, an estimated $115.
  • Merck made up 0.16% of Aspen Wealth Strategies's portfolio in Q1 2026, its #74 holding.
  • Aspen Wealth Strategies first reported a position in Merck in Q4 2022 and has held it in 13 quarters since.
  • Aspen Wealth Strategies's Merck position peaked at $338K in Q2 2024.
  • 3,778 funds tracked by Wall St. Rank held Merck as of Q1 2026.

Based on Aspen Wealth Strategies's 13F filing for Q1 2026, filed 8 May 2026.